SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zenith Healthcare informs about amalgamation

15 Jul 2026 Evaluate
Zenith Healthcare has informed that the Board of Directors of the Company, at its meeting held on  July 14, 2026 (Tuesday) at the registered office of the Company, after considering the recommendation of the Audit Committee and the Committee of Independent Directors of the Company, has considered and approved a Scheme of Amalgamation of Achyut Healthcare Limited (Transferor Company) with and into Zenith Healthcare (Transferee Company) and their respective shareholders and creditors (Scheme), under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (Act), rules and regulations made thereunder read with Section 2(6) of the Income Tax Act, 2025, for the aforementioned amalgamation, consequent dissolution of the Transferor Company without winding up and the issuance of equity shares by the Transferee Company to the equity shareholders of the Transferor Company as consideration. The Scheme is subject to requisite approvals and sanction of the appropriate statutory and regulatory authorities including jurisdictional bench of the National Company Law Tribunal (NCLT) and subject to the approval of shareholders and/or creditors. Further, the Scheme shall be filed with BSE Limited for obtaining the no-objection letter/ observation letter in terms of Regulation 37(1) of the SEB] LODR Regulations read with SEBI Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 dated June 20, 2023.

The above information is a part of company’s filings submitted to BSE.

Zenith Health Care Share Price

3.20 0.00 (0.00%)
29-Jul-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1989.75
Dr. Reddys Labs. 1143.20
Cipla 1473.45
Lupin 2446.00
Zydus Lifesciences 1122.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: